Insider Trades And Rare Disease Growth Shape ANI Pharmaceuticals Valuation [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Senior executives at ANI Pharmaceuticals (NasdaqGM:ANIP) recently reported fresh insider transactions, including purchases and sales. SVP Krista Davis disclosed an insider share purchase, while CFO Stephen P Carey reported an option exercise and related share sale. These moves come alongside continued reported growth in ANI's Rare Disease and Generics businesses and a standout Q4 performance. ANI Pharmaceuticals focuses on Rare Disease therapies and Generics, two areas that can draw attention when companies report solid operational momentum. With reported strength in these businesses and Q4 results that management has highlighted, new insider activity provides another datapoint on how leadership is acting as the company executes its plan. Insider buying and selling does not guarantee a particular outcome for the stock, but many investors track these filings as one pie
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- ANI Pharmaceuticals Targets $1.1B 2026 Revenue as Cortrophin Sales Surge, Gout Launch Set for Midyear [Yahoo! Finance]Yahoo! Finance
- Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Q4 2025: Strong Growth, But Execution Risks Emerge [Seeking Alpha]Seeking Alpha
ANIP
Earnings
- 2/27/26 - Beat
ANIP
Sec Filings
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- ANIP's page on the SEC website